Bionano Genomics, Inc.
BNGONASDAQHealthcare● Active
$1.18
+$0.01(+0.43%)
Market Cap$3858008
P/E Ratio—
52W High$5.5
52W Low$1.06
Bionano Genomics, Inc. (BNGO) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · BNGO · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $28.51M | $30.78M | $36.12M | $27.80M | $17.98M |
| Cost of Revenue | $22.25M | $30.40M | $26.55M | $21.86M | $14.11M |
| Gross Profit | $6.26M | $0.38M | $9.57M | $5.95M | $3.87M |
| Gross Margin %(computed) | 21.95% | 1.23% | 26.49% | 21.38% | 21.54% |
| Operating Expenses | |||||
| R&D Expenses | $11.37M | $24.80M | $54.03M | $49.05M | $22.48M |
| G&A Expenses | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Total Operating Expenses | $39.60M | $104.36M | $224.81M | $137.64M | $80.97M |
| Operating Income | ($33.34M) | ($103.98M) | ($215.25M) | ($131.70M) | ($77.10M) |
| Operating Margin %(computed) | -116.95% | -337.87% | -595.98% | -473.70% | -428.79% |
| Interest Income | $1.11M | $2.10M | $3.31M | $1.51M | $0.24M |
| Interest Expense | $0.30M | $0.29M | $5.12M | $0.30M | $0.93M |
| Income Before Tax | ($26.33M) | ($111.98M) | ($232.43M) | ($130.71M) | ($78.15M) |
| Income Tax Expense | $0.07M | $0.03M | $0.06M | $1.88M | ($5.72M) |
| Net Income | ($26.39M) | ($112.02M) | ($232.49M) | ($132.60M) | ($72.44M) |
| Net Margin %(computed) | -92.59% | -363.98% | -643.74% | -476.93% | -402.84% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-4.85 | $-88.13 | $-408.48 | $-267.71 | $-157.02 |
| Wtd Avg Shares | 5.45M | 1.90M | 0.58M | 0.49M | 0.47M |
| EBITDA | ($23.61M) | ($97.47M) | ($213.60M) | ($120.31M) | ($73.86M) |
| EBITDA Margin %(computed) | -82.81% | -316.70% | -591.44% | -432.76% | -410.74% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · M
Explore more Bionano Genomics, Inc. data
About Bionano Genomics, Inc. (BNGO) Income Statement
Bionano Genomics, Inc. (BNGO) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, BNGO reported revenue of $0.03B, gross profit of $0.01B (gross margin 21.95%), and net income of ($0.03B) — a net profit margin of -92.59%.
Frequently asked questions
BNGO · 4 questionsBionano Genomics, Inc. (BNGO) reported revenue of $0.03B for 2025, down 7.4% year-over-year.
BNGO revenueBNGO salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08